PreCision Dermatology, Inc.

📍 Cumberland, United States🗓 Founded 2010👥 23 employees💰 Last funded Jun 2010
Pharmaceutical Manufacturing🌐 valeant.com
Website LinkedIn
Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology PR Newswire -8 July 2014 - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of PreCision Dermatology, Inc. PreCision develops and markets high quality dermatology products with leading products such as Locoid, Hylatopic, and Clindagel. About Valeant Pharmaceuticals International, Inc. Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in PreCision Dermatology, Inc.?
PreCision Dermatology, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did PreCision Dermatology, Inc. last raise funding?
The most recent investment in PreCision Dermatology, Inc. recorded on gritt.io was in June 2010.
When was PreCision Dermatology, Inc. founded?
PreCision Dermatology, Inc. was founded in 2010.
What industry is PreCision Dermatology, Inc. in?
PreCision Dermatology, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is PreCision Dermatology, Inc. based?
PreCision Dermatology, Inc. is headquartered in Cumberland, United States.